Antitrust & Trade Regulations Antitrust Intellectual Property Antitrust and Competition Law Federal Circuit and IP Appeals Intellectual Prop. Intellectual Property Issues and Appeals Litigation Patent Securities & Corporate Finance Securities Law Trademark and Copyright
ISLN:
909658548
Admitted:
1994
University:
Ripon College, B.A., 1986; University of Wisconsin, Madison, B.S.E.E., 1988
General Dynamics Information Technology Mayport, FL Sep 2009 to Feb 2010 Laborer/InstallerPETV IN HOME SERVICE Jacksonville, FL Dec 2007 to Jan 2009 Owner TV serviceEXPEDITED SHIPPING SOLUTIONS Jacksonville, FL May 2006 to May 2007 Driver/warehouse workerSEARS Jacksonville, FL Apr 2004 to May 2006 Home electronics technicianSOUND ADVICE Jacksonville, FL Aug 2000 to Mar 2004 Television road technicianTELEVISION CITY Jacksonville, FL Jan 1992 to Dec 1999 Television technician and sales
Education:
Technical or Vocational School Jul 1977 Vocational in Basic Electronics//Color Television Electronics
Takeda Pharmaceuticals USA president Douglas Cole said, "Takeda is pleased with the FDA approval of NESINA, OSENI and KAZANO for the treatment of type 2 diabetes, a therapeutic category in which we have more than twenty years of clinical and patient experience."
Date: Jan 29, 2013
Category: Health
Source: Google
Takeda Diabetes Drug Succeeding Actos Wins FDA Approval
Millions of people are affected by diabetes and, as aleader in the diabetes arena, Takeda is dedicated to working toadvance patient care and helping to meet the needs of thisgrowing patient population, Douglas Cole, president ofTakedas U.S. subsidiary, said in a statement.
Date: Jan 27, 2013
Category: Health
Source: Google
Takeda seeks to corner market on gout with $800 million acquisition
Douglas Cole, president of Takeda Pharmaceuticals U.S.A. Inc., said the primary goal of the URL acquisition was to gain Colcrys, "so we can be the only company that treats both acute and chronic gout."
This acquisition expands Takedas gout treatment portfolio and leverages our expertise in primary care, said Douglas Cole, president of Takeda Pharmaceuticals U.S.A. We are pleased to have URL Pharmas Colcrys added to our product portfolio.
Past: Group Communications Officer at NYK Line (North America), Sr. Manager Sales Adminstration... An award-winning “C-level” marketing executive with unparalleled success in all areas of group communications, public relations, new business development... An award-winning “C-level” marketing executive with unparalleled success in all areas of group communications, public relations, new business development and advertising. Analytical, intelligent, and self motivated professional with more than 20 years of experience creating and developing...